Malaria is the leading cause of sickness and death in Uganda. Prevention, correct diagnosis and treatment are crucial to reduce malaria cases and mortality as well as lower the risk of resistance to antimalarial medicines and decrease medicine waste and misuse. However, due to inappropriate practice...
Healthcare workforce development is critical to meeting Sustainable Development Goal 3 (SDG3) and other health-related SDGs and to achieve universal healthcare coverage (UHC)2(p3) in Africa. The COVID-19 pandemic further compounds the already ill equipped, under-staffed strained, and over-stretched...
This document has been produced in order to help those working with men, specifically in the field of HIV prevention as well as more broadly in the areas of improved sexual and reproductive health.
Accurate determination of iron status is crucial for diagnostic and screening purposes in the clinical setting and to guide public health interventions at the population level. In an individual patient, diagnosis of iron deficiency or overload will help guide management, including further investigat...
This issue focuses on the first quarter of 2019/2020 financial year. The aim of this bulletin is to inform district, national, and global stake-holders on progress achieved and challenges encountered in malaria control and reduction in Uganda. Most importantly, it is to encourage use of this informa...
This document simplifies the WHO guidance on severe acute respiratory infection (SARI) treatment centres and is meant to be accessible to healthcare workers, policymakers and others who want a quick overview of the key requirements for a COVID-19 isolation centre either within an existing facility o...
The document titled Outbreak Brief 153: Coronavirus Disease 2019 (COVID-19) Pandemic offers a comprehensive insight into Surveillance and Disease Intelligence, focusing on key issues related to Technical Guidance. It addresses critical health challenges within Central Africa, Eastern Africa, Norther...
It is the responsibility of governments to assure a safe and sufficient supply of blood and blood products for all patients requiring transfusion (1). Each country�should formulate a national blood policy and plan, as part of the national health policy, to define how safe blood and blood products w...
The document titled Guidance on Environmental decontamination offers a comprehensive insight into Emergency Response and Preparedness, focusing on key issues related to Technical Guidance. It addresses critical health challenges within Central Africa, Eastern Africa, Northern Africa, Southern Africa...
Antiretroviral medicines Public sector: NMS is well stocked with ARV medicines above 3 MOS except EFV 600mg, ATV/r 300/100mg and LPV/r 100/25mg with less than 3 MOS. Stock is available in country for TDF/3TC/EFV 300/300/600mg (3.5 MOS), TDF/3TC/DTG 300/300/50mg (3.1 MOS), DTG 50mg (4.2 MOS), ABC/3TC...
The development of this National Medicines Policy (NMP) 2015 has been informed by the second National Health Policy (NHP) 2010, the Health Sector Development Plan (HSDP) 2015- 2020, the current state of the pharmaceutical sector and global health
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and int...
Public Sector: ARV medicines are well stocked except except TLE formulations, ABC/3TC 600/300mg, LPV/r 200/50mg and ABC/3TC 120/60mg. Stock is available incountry for TLD 90 pack (2.0 MOS) and DTG 50mg (13.6 MOS). Interwarehouse transfer of TLD 90 pack (1.3 MOS) and DTG from JMS to be effected in Au...
The Ministry of Health hereby presents the Statistical Abstract, 2002. The Health Management Information System (HMIS) and Morbidity and Mortality surveys by the Resource Center of the Ministry of Health and partner agencies yield a wide range of health and Health related statistics. These help to m...
The document titled Outbreak Brief 94: Coronavirus Disease 2019 (COVID-19) Pandemic offers a comprehensive insight into Emergency Response and Preparedness, focusing on key issues related to Technical Guidance. It addresses critical health challenges within Central Africa, Eastern Africa, Northern A...
This epidemiological bulletin serves to inform all stakeholders at district, national, and global levels on disease trends, public health surveillance and interventions undertaken in detecting, preventing and responding to public health events in the country on a weekly basis. In this issue, we brin...
These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the care of people living with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. The guidelines are structured along the continuum of HIV testing, prevention, tr...
A WHO Technical Consultation on Antimalarial Combination Therapy was held in Geneva, Switzerland on 4 and 5 April 2001. Participants reflected a wide range of expertise in the development and use of antimalarial drugs (Annex 1).
This document is one of two evidence-based cornerstones of the World Health Organization��s (WHO) new initiative to develop and implement evidence-based guidelines for family planning. The first cornerstone, the Medical eligibility criteria for contraceptive use (third edition) published in 2004, pr...
Timeline – Slide 3economyHiring of Consulting Firms – Consultancy Services – Slide 4Procurement of Goods – Slide 5TimelineProcurement of Goods and Services under Workshop/Technical Assistance/Training – Slide 6
